Related Experiment Videos
An immunotoxicity screening study on salmeterol in rats
E J de Waal1, W H de Jong, H van der Vliet
1National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
International Journal of Immunopharmacology
|August 1, 1996
Summary
This study investigated salmeterol
Area of Science:
- Pharmacology
- Toxicology
- Immunology
Background:
- Salmeterol is a long-acting beta 2-adrenoreceptor agonist.
- Its immunotoxic potential requires thorough investigation.
- A 28-day repeated dose toxicity study in Wistar rats was conducted.
Purpose of the Study:
- To assess the immunotoxic potential of salmeterol.
- To evaluate the effects of salmeterol on various immunotoxicity screening parameters.
- To determine dose-dependent effects on immune markers.
Main Methods:
- Wistar rats were orally administered 0, 0.2, 2, or 20 mg/kg/day salmeterol.
- Dose was adjusted to 10 mg/kg/day for the highest group due to adverse events.
- Parameters included body weight, bone marrow cellularity, hematology, organ weights, histopathology, serum immunoglobulin levels, and splenic B cell counts.
Main Results:
- Decreased platelet counts, liver weights, and absolute thymic weights were observed at various doses.
- Increased serum IgM and IgG levels were noted at specific dose levels.
- A decrease in splenic B cell numbers was observed across all tested doses.
Conclusions:
- The applied test battery effectively detected low immunotoxic potential of salmeterol.
- Further research is warranted to explore salmeterol's impact on immune responses following antigenic challenge.
- Salmeterol demonstrated some immunomodulatory effects in rats at tested doses.